HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, View ORCID ProfileAthe Tsibris
doi: https://doi.org/10.1101/2023.05.26.23290576
Tyler Lilie
1Brigham and Women’s Hospital, Boston, MA, USA
Jennifer Bouzy
1Brigham and Women’s Hospital, Boston, MA, USA
Archana Asundi
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
Jessica Taylor
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
3Grayken Center for Addiction, Boston Medical Center, Boston, MA USA
Samantha Roche
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
Alex Olson
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
Kendyll Coxen
1Brigham and Women’s Hospital, Boston, MA, USA
Heather Corry
1Brigham and Women’s Hospital, Boston, MA, USA
Hannah Jordan
1Brigham and Women’s Hospital, Boston, MA, USA
Kiera Clayton
4Department of Pathology, University of Massachusetts T.H. Chan School of Medicine, Worcester, MA, USA
Nina Lin
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
Athe Tsibris
1Brigham and Women’s Hospital, Boston, MA, USA
5Harvard Medical School, Boston, MA, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted June 04, 2024.
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, Athe Tsibris
medRxiv 2023.05.26.23290576; doi: https://doi.org/10.1101/2023.05.26.23290576
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, Athe Tsibris
medRxiv 2023.05.26.23290576; doi: https://doi.org/10.1101/2023.05.26.23290576
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)